Literature DB >> 3963983

Therapy of Mycobacterium marinum infections. Use of tetracyclines vs rifampin.

S T Donta, P W Smith, R E Levitz, R Quintiliani.   

Abstract

We describe four patients with Mycobacterium marinum infections who did not respond to two- to six-week courses of therapy with tetracycline, minocycline, and doxycycline. All four patients had prompt responses to therapy with either rifampin alone (two patients) or rifampin in combination with ethambutol. Results of antimicrobial sensitivity tests may be helpful in guiding therapy. Rifampin may be the drug of choice for treatment of these infections.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3963983

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  6 in total

1.  A case of disseminated Mycobacterium marinum infection in an immunocompetent patient.

Authors:  J A Vazquez; J D Sobel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Short course monotherapy with clarithromycin for localized Mycobacterium marinum skin infection.

Authors:  M R Weinstein; D E Low; T Mazzulli
Journal:  Can J Infect Dis       Date:  1997-05

3.  Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman.

Authors:  R B Clark; H Spector; D M Friedman; K J Oldrati; C L Young; S C Nelson
Journal:  J Clin Microbiol       Date:  1990-11       Impact factor: 5.948

4.  Antibiotic susceptibility pattern of Mycobacterium marinum.

Authors:  A Aubry; V Jarlier; S Escolano; C Truffot-Pernot; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

Review 5.  Mycobacterium marinum: ubiquitous agent of waterborne granulomatous skin infections.

Authors:  B Petrini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-10       Impact factor: 5.103

6.  Fish tank granuloma caused by Mycobacterium marinum.

Authors:  Ting-Shu Wu; Cheng-Hsun Chiu; Chih-Hsun Yang; Hsieh-Shong Leu; Ching-Tai Huang; Yi-Chieh Chen; Tsu-Lan Wu; Pi-Yueh Chang; Lin-Hui Su; An-Jing Kuo; Ju-Hsin Chia; Chia-Chen Lu; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-07-20       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.